Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-27

Clinical Trial Update: Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/Phase 2 trial evaluating intravenous ascorbic acid supplementation in neoadjuvant chemotherapy for breast cancer; the current status is u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous ascorbic acid supplementation (ascorbic acid)

Snippet

Sponsor: Academic Emergency County Hospital Sibiu | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN